Sleep Promotion and Pediatric Hypertension

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Children's Hospital of Philadelphia
Study ID
NCT06642246
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
13 Years - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • Intervention — BEHAVIORAL
    During a 7-week intervention phase, parent-child dyads will be provided a sleep duration goal paired with a loss-framed financial incentive (virtual account) starting with deductions each time the sleep goal is not met, will be sent sleep guidance text messages, and will receive weekly performance feedback text messages.

Study Details

Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.

Key Dates

Start date
Feb 16, 2026
Status verified
Feb 2026
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Arm 1
    Sleep goal, Sleep guidance messaging, Loss-framed incentive, Supportive feedback.

Primary Outcome Measure

Hypertension [ Time Frame: From baseline to approximately week 11 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19146
Jonathan Mitchell
267-426-1473
Abby Salem
215-590-2386
Jonathan Mitchell, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Philadelphia, PA

Related Studies